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Abstract The tripeptide, N-octanoyl-Asn-[‘251]Tyr-Thr-NH,, which contains the acceptor sequence for N-glycosylation, is readily taken up by cell 
culture cells, glycosylated in the endoplasmic reticulum (ER), and secreted into the medium. Therefore such glycosylated tripeptides have been used 
as markers for the vesicular flow from the endoplasmic reticulum to the plasma membrane [(1987) Cell 50, 289-300; (1990) J. Biol. Chem. 265, 
20027-200321. We have now studied the pathway taken by the glycotripeptides in mammals in more detail. In the perfused rat liver, the 
glycotripeptides ecreted to the medium were analyzed by digestion with exoglycosidases, and a significant fraction was found to contain the 
terminating sequence -Gal-Sial, which is generated by processing enzymes that reside in the late Golgi apparatus. Thus we conclude that these 
glycotripeptides have passed through the complete Golgi complex on their way from the ER to the cell surface. 
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1. Introduction 
Tripeptides with a hydrophobically modified amino termi- 
nus, a blocked carboxyl terminus and the sequence necessary 
for N-glycosylation, Asn-Xaa-Ser/Thr, are readily taken up by 
living cells and glycosylated in the endoplasmic reticulum (ER) 
[1,3]. Once glycosylation has occurred, however, they are no 
longer able to permeate membranes and must be actively trans- 
ported out of the ER if they are to be secreted. This transport 
is presumed to occur by the constitutive secretory pathway, 
which proceeds in vesicles from the endoplasmic reticulum 
through the Golgi complex to the plasma membrane [1,4]. Gly- 
cosylated N-octanoyl-Asn-[“‘I]Tyr-Thr-amides (glyco-OTP) 
are highly unlikely to contain any transport or retention signals, 
and therefore have been used to determine the rate at which 
bulk material travels along the secretory pathway. Resistance 
to endoglycosidase H (Endo H), typically acquired in the me- 
dial Golgi, of the glycotripeptides ecreted from Chinese ham- 
ster ovary (CHO) cells [l] as well as dependence of secretion 
on ATP, cytosol and GTP hydrolysis in semi-intact CHO cells 
[2] were taken as indication that the glycotripeptides are trans- 
ported through the Golgi in a vesicular fashion, indeed similar 
to newly synthesized secretory proteins. 
Investigation of the [“‘I]glycotripeptide species secreted by 
CHO and HepG2 cells had not given conclusive evidence for 
a passage through the complete Golgi apparatus, as modifica- 
tions with galactose and sialic acid, typically acquired in the 
‘late’ Golgi, were not detected [l]. The resistance observed to 
Endo H is acquired already in the medial Golgi [S], and conse- 
quently, complete passage of the glycotripeptides through the 
Golgi apparatus, including the trans Golgi, has been challenged 
[6,7]. In order to investigate the complete pathway taken by 
these glycopeptides, we therefore studied their secretion in per- 
fused rat liver, a system that most closely resembles in vivo 
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conditions. We report here a glycosylation structure typical of 
late Golgi processing of the carbohydrate chain of a major 
portion of the glycotripeptides ecreted to the medium, imply- 
ing that [‘2SI]glyco-OTP indeed passes through the complete 
Golgi apparatus on its way to the cell surface in rat liver. 
2. Experimental 
2.1. Peptide synthesis and iodination 
OTP was synthesized by solid phase peptide synthesis employing 
Fmoc amino acids according to [l]. “‘1 iodination was performed as 
described [l] using the chloramine T procedure. Specific activity ranged 
from 1 to 2 x IO8 cpm/nmol. The iodinated tripeptide was dissolved in 
dimethyl sulfoxide at 5 x lo6 cpm/pl. 
2.2. Liver perfusion 
Liver perfusion experiments were carried out essentially as described 
[8]. The liver was removed from 200 g male Wistar rats anesthetized 
with Evipan (Bayer, Leverkusen, Germany). The perfusion medium 
consisted of RPM1 1640 (Seromed) supplemented with NaHCO, (2000 
mg/l) and 1% (w/v) bovine serum albumin. After erythrocytes had been 
washed out, 50 ml medium was circulated through the liver, and 600 
PCi (25 pg) [‘*‘I]OTP in 100 ~1 dimethyl sulfoxide diluted 1:lO with 
perfusion medium was added. After 60 min, the medium was collected 
and [‘251]glyco-OTP was isolated from 1 ml aliquots by ConA-Sepha- 
rose chromatography as described [l]. The liver was cut into small 
pieces, suspended at 250 mg/ml in ice-cold buffer A (10 mM Tris-HC1 
pH 7.4,0.15 M NaCl, 1 mM CaCI,, 1 mM MnCI,, 0.5% Triton X-100), 
shredded with an Ultra-Turrax (Ika, Staufen/Germany), filtered 
through cheesecloth, and homogenized in a Potter-Elvehjem homoge- 
nizer with motor-driven pistle at 4 “C. The homogenate was centrifuged 
at 1400 rpm (400 x g) for 5 min in a Heraeus Omnifuge. The super- 
natant was heated to 95°C for 2 min, recentrifuged, and 1 ml aliquots 
of this supematant were applied to ConA-Sepharose columns. 
[1251]glyco-OTP was eluted with 0.5 M methyl-a-o-mannopyranoside as 
described [I]. 
2.3. Incubations with Brefeldin A 
Wild-type CHO cells were grown in suspension cultures in a-MEM 
(Gibco) as described by Balch et al. [9]. For incubations with Brefeldin 
A, cells were preincubated in the presence of Brefeldin A (10 &ml), 
added from a 10 mg/ml stock solution in methanol. The same amount 
of methanol was added to control cells. After 30 min preincubation, 
cells were centrifuged (400 x g, 5 min) and resuspended in a-MEM 
supplemented with Brefeldin A (IOfig/ml) or the corresponding volume 
of methanol (control) at 1 x IO’ cells/ml. As a control for Brefeldin A 
action, an increase of sphingomyelin synthesis was measured according 
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to Briining et al. [lo]. Further incubation procedures were as described 
by Wieland et al. [l]. 
Rat liver perfusion experiments with Brefeldin A were carried out by 
continuously pumping fresh RPM1 1640 medium with NaHCO, (2000 
mg/l) either with or without 20 fig BFA/ ml through the liver at a rate 
of 7 ml/min. [‘*‘I]OTP was added after a 15-min pulse with 1 mCi 
[“S]methionine/cysteine. Chase medium contained 5 mM each of 
methionine and cysteine. Five minute medium fractions were collected, 
and [“‘I]glyco-0TP was isolated from one third of the fractions by 
ConA-Sepharose chromatography. “S-Labeled secretory proteins were 
immunoprecipitated from another third of the fractions with an anti- 
body against rat whole serum (Sigma). 
2.4. Glycotripeptide analysis 
Glycotripeptides eluted from ConA Sepharose columns in buffer A 
without Triton X-100 were applied to a SepPak C-18 cartridge (Wa- 
ters), washed with 20 ml H,O, eluted with 60% Acetonitrile and dried 
in a SpeedVac oncentrator. About l-5 ~1 of an aqueous solution of 
the concentrate was spotted onto a silica gel thin layer plate with 
grooved channels (Whatman). Chromatography was performed in bu- 
tanollacetic acid/water (5 : 2: 2, v/v/v). The TLC plates were dried thor- 
oughly and exposed to X-ray film (Kodak XARS) at -70 “C, using an 
intensifying screen (DuPont Cronex Hi-plus). Enzymatic digestions of 
glycotripeptides were usually carried out over night in X-l 1 buffer, pH 
5.5, supplied by Oxford Glycosystems, except for N-glycanase diges- 
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tions, which were performed in a 50 mM sodium phosphate buffer, pH 
7.5. Glycosidases were from Oxford Glycosystems, except for Endo H 
and N-glycanase (Boehringer). Digestions in which several enzymes 
were used were carried out either sequentially or simultaneously, both 
procedures giving the same results. 
3. Results 
3.1. Glycotripeptides secreted by the perfused rat liver contain 
sialic acid 
In order to study [‘251]glycotripeptide secretion in mammals 
more closely with regard to the pathway taken, [‘251]OTP was 
added to the medium of a perfused rat liver. The intracellularly 
formed [‘251]glycotripeptides (4% of added [‘251]OTP) were iso- 
lated after one hour perfusion from the homogenized liver and 
the perfusion medium, respectively. Following enzymatic diges- 
tion with various glycosidases, the [‘251]glycotripeptides from 
liver extract and medium were analyzed by thin-layer chroma- 
tography (TLC) and autoradiography (Fig. 1A). [‘251]Glyco- 
tripeptides recovered from the liver were not susceptible to 
sialidase treatment (see Fig. lA, lanes 1 and 2), and were 
C 
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Fig. 1. Carbohydrate chain analysis by sequential enzymatic digestion of [?]glycotripeptides isolated from the perfused rat liver and the perfusion 
medium. Panel A, [‘251]glycotripeptides w re isolated from a liver homogenate and from the perfusion medium after one hour of perfusion as described 
in section 2, and incubated for 16 h with the glycosidases indicated. Panel B, simultaneous digestion of [‘*‘I]glycotripeptides from the perfusion medium 
with the glycosidases indicated. Panel C, [“‘Ilglycotripeptides before and after reperfusion (see text). Lane 1, liver extracted material before reperfusion 
(as in lane 1 of panel A); lane 2, [“‘I]glycotripeptides reisolated from the perfusion medium; lane 3, the material from lane 2 after digestion with 
sialidase. 
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Fig. 2. Secretion by the perfused rat liver of 35S-labeled proteins and 
[‘*‘I]glycotripeptides in the absence and presence of Brefeldin A. Panel 
A, %-labeled secretory proteins were immunoprecipitated from the 
medium of the perfused rat liver with an antibody against rat whole 
serum. The rate of secretion is given as immunoprecipitated ‘5S-cpm/10 
min fraction in the absence and presence of Brefeldin A. Panel B, 
secretion of [‘251]glycotripeptides in the absence and presence of 
Brefeldin A. cpm of combined 10 min fractions are given. Panel C, 
carbohydrate chain analysis of [“‘I]glycotripeptides ecreted by the 
perfused rat liver in the absence (lanes l-5) and presence (lanes 610) 
of Brefeldin A. 
completely hydrolyzed by Endo H (lane 4). This material was 
also cleaved by Jack Bean a-mannosidase (lane 3), an exoglyco- 
sidase which cleaves off terminal mannose residues bound in 
a-linkage. The TLC spot arising from this digestion should 
correspond to the peptide backbone connected to two N-acetyl- 
glucosamines and a/3-bound mannose, while Endo H treatment 
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leaves only the innermost N-acetyl-glucosamine attached to the 
peptide. From these digestions, high-mannose structures can be 
deduced for the carbohydrate chains present in the liver frac- 
tion [5]. 
[‘251]Glycotripeptides isolated from the perfusion medium, 
which accounted for 3.5% of the [*2SI]glycotripeptides formed, 
showed a different glycosylation pattern (Fig. lA, lanes 610). 
The slowest migrating spot in TLC, which comprised 30% of 
the radioactivity in lane 6, was no longer present after sialidase 
treatment, and at the same time completely resistant to Endo 
H. The remainder of the [‘251]labeled material in lane 6 was 
cleaved by Endo H as well as by Jack Bean a-mannosidase, and 
is therefore considered to represent high-mannose type oligo- 
saccharide structures. 
The Endo H resistant material was investigated in more de- 
tail by treating the secreted [‘251]glycotripeptides with exoglyco- 
sidases (in the presence of Endo H to eliminate the faster- 
migrating high-mannose species) and subsequent analysis by 
TLC and autoradiography (Fig. 1B). A sequentially higher 
mobility after sialidase and sialidase/ I-galactosidase digestion 
was observed that indicates a glycosylation pattern typical of 
complex carbohydrates, which are formed by the sequential 
processing of the carbohydrate chain by glycosyl transferases 
residing in the cis (Golgi a-mannosidase I), medial (N-acetylglu- 
cosaminyltransferases I and II and Golgi a-mannosidase II), 
and tram Golgi (galactosyltransferase and sialyltransferase) 
[5,11-131. 
Although this finding suggests that the secreted glycotripep- 
tides have passed through the complete Golgi apparatus, it 
cannot be excluded that the galactosyl and sialic acid residues 
have been acquired by [rz51]glycotripeptides that had been se- 
creted as high mannose types in the first place and subsequently 
taken up by the cells with reprocessing of their carbohydrate 
structures, as described for the cell-surface expressed ipepti- 
dylpeptidase IV [14]. 
In order to investigate this possibility, a [“‘I]glycotripeptide 
fraction isolated from the liver homogenate (that contained 
exclusively high-mannose chains, see above) was added to the 
medium of another perfused rat liver. After 1 h of reperfusion, 
[‘251]glycotripeptides were re-isolated by ConA sepharose col- 
umn chromatography. While 10% of the recovered radioactiv- 
ity was associated with the liver, this material no longer bound 
to Concanavalin A Sepharose, presumably because it was de- 
graded. Likewise, 14% of the radioactivity recovered from the 
medium did not bind to Concanavalin A sepharose. The re- 
isolated material bound to ConA Sepharose was again analyzed 
by TLC and autoradiography. As shown in Fig. lC, the glyco- 
sylation pattern had been altered only slightly by the reperfu- 
sion, with an additional, faster-migrating spot which, however, 
is not susceptible to sialidase digestion. The slower-migrating 
spot from Fig. lA, lane 6, which we have shown to contain 
sialic acid, does not appear. Thus, sialylation is not due to 
reuptake by the liver and must therefore have occurred during 
passage of the secreted [1251]glycotripeptides through the com- 
plete Golgi apparatus along the biosynthetic secretory path- 
way. 
3.2. Brefeldin A does not inhibit secretion of 
f’2’I]glycotr@eptides 
The fungal metabolite Brefeldin A is known to inhibit secre- 
tion of proteins in various cell lines by a mechanism which is 
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not yet fully understood but which results in dissociation of the 
Golgi complex and partial redistribution of Golgi markers to 
the ER [15,16]. Therefore, we expected this antibiotic to inhibit 
[‘251]glycotripeptide secretion in cells that are susceptible to 
Brefeldin A. Surprisingly, however, when the drug is added to 
CHO cells, the [‘251]glycotripeptides are secreted at the same 
rate as in the untreated control (not shown). The action of 
Brefeldin A under the conditions applied was monitored by 
measurement of an increase of truncated sphingomyelin syn- 
thesis according to Briining et al. [lo] (not shown). 
This unexpected result prompted us to analyze the [“‘I]gly- 
cotripeptides formed in rat liver perfused in the presence of 
BFA. To this end, BFA was added in a high concentration (20 
@/ml) to the perfusion medium. In order to maintain an effi- 
cient concentration of the antibiotic, which is degraded effi- 
ciently by glutathion-S-transferase [ 171, the perfusion medium 
was not recycled in these experiments. As a control for the 
action of BFA we monitored the secretion of 35S-labeled pro- 
teins into the medium by immunoprecipitation with anti-rat 
serum antibodies. In a first experiment, perfusion after addition 
of [‘251]OTP was for 70 min in the absence of BFA, and subse- 
quently for 50 min in the presence of BFA. The result is shown 
in Fig. 2. Although not blocked completely, protein secretion 
was reduced significantly by 70% (Fig. 2A). In contrast, secre- 
tion of [‘251]glycotripeptides was not affected at all (Fig. 2B). 
A comparison of the [‘251]glycotripeptide fractions obtained 
from the media in the absence and presence of BFA is given 
in Fig. 2C).Without BFA, the pattern shown in Fig. 1 was 
confirmed. The slowest migrating species again could be as- 
signed to glycopeptides containing -Gal-Sial. However, this 
type of complex carbohydrate is missing in the fraction ob- 
tained in the presence of BFA. Instead, most of the material 
represents ‘high-mannose’ forms. This change of carbohydrate 
structures in the secreted [‘251]glycotripeptides is reversible, as 
shown in Fig. 3. In this experiment, [‘251]OTP was added to the 
medium after 15 min of perfusion with BFA. After additional 
60 min in the presence of BFA, perfusion was continued for 
another 30 min in the absence of BFA. Protein secretion was 
reduced to 25% as compared to the secretion observed in the 
absence of BFA in a control experiment (see Fig. 2A). Switch- 
ing from medium + BFA to medium -BFA resulted in an 
increase of protein secretion by 145% (Fig. 3A), indicating 
reversibility of the BFA effect on protein secretion in this sys- 
tem, whereas [‘251]glycotripeptide s cretion was not signifi- 
cantly increased (Fig. 3B). Analysis of the glycotripeptide frac- 
tions isolated from the respective media clearly demonstrates 
that the effect of BFA on the carbohydrate structures was 
reversible, as depicted in lanes 610 of Fig. 3C). 
4. Discussion 
In this paper, we have demonstrated that about 30% of the 
[‘*‘I]glycotripeptides ecreted by rat liver possess a complex 
carbohydrate chain that would require passage through the 
entire Golgi complex. Not all of the [‘251]glycotripeptides s -
creted have been processed, but it is surprising, anyway, that 
all of the sequential processing steps which are necessary for 
complex glycosylation can be performed on glyco-OTP with 
any degree of efficiency, as additional signals for glycoprotein 
processing are presumed to be needed, considering that secre- 
tory proteins can differ markedly with regard to their oligosac- 
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Fig. 3. Reversibility of the effects of Brefeldin A on protein secretion 
and [“‘r]glycotripeptide glycosylation. Panel A, immunoprecipitated 
%-labeled secretory proteins. Panel B, secretion of [‘251]glycotripep- 
tides in the presence and absence of Brefeldin A. Panel C, carbohydrate 
chain analysis of [“‘I]glycotripeptides secreted by the perfused rat liver 
in the presence (!anes l-5) and absence (lanes 610) of Brefeldin A. 
charide structures. Also, most N-glycosylated sites in eukar- 
yotic glycoproteins are associated with several different oligo- 
saccharide structures [18]. These results for the first time pro- 
vide evidence for passage of the glycotripeptides through the 
complete secretory pathway from the ER via the entire Golgi 
complex to the plasma membrane. 
Brefeldin A does not inhibit secretion of [‘251]glycotripep- 
tides, neither in CHO cells nor in the perfused rat liver. This 
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suggests a major difference in the transport properties of gly- 
cotripeptides as compared to proteins. One possible explana- 
tion that seems to be ruled out is the alternative secretory 
pathway recently reported for some secretory proteins (re- 
viewed in [19]). These proteins seem to bypass the ER, since 
they lack cleavable signal sequences and are not glycosylated 
although some of them contain the consensus sequence for 
N-glycosylation. N-Glycosylation within the ER, however, is 
the prerequisite for formation of [‘251]glyco-OTF’. This leaves 
two possibilities: (a) under physiological conditions, proteins 
and glycotripeptides employ the same set of transport vesicles, 
but under the non-physiological conditions imposed by Bre- 
feldin A, a novel transport pathway is opened which cannot be 
taken by proteins, but is only available to small luminal mole- 
cules; or (b) proteins and small molecules such as the [‘251]gly- 
cotripeptides are secreted by different sets of transport vesicles, 
both types of vesicle passing the complete Golgi apparatus. In 
this case, Brefeldin A would not inhibit the pathway taken by 
small molecules. Evidence for this latter possibility can be 
found in the literature [20]. Newly synthesized cholesterol is 
present in vesicles that on sucrose density gradients comigrated 
with newly synthesized vesicular stomatitis virus (WV) G pro- 
tein, known to pass through the Golgi stack. However, cholest- 
erol transport to the cell surface occurred with the same kinetics 
in the presence or absence of Brefeldin A, in agreement with 
our findings for the glycotripeptides. Similar observations have 
recently been published for sphingomyelin transport [21]. 
Regarding the application of the glycotripeptides as markers 
for vesicular bulk flow in mammalian cells, one important con- 
clusion we had drawn previously [l] needs to be modified in 
light of data accumulated since. The glycopeptides were found 
to be transported to the cell surface as fast as the fastest known 
newly synthesized protein, and therefore we had concluded that 
cargo proteins are not concentrated uring budding of an ER 
transport vesicle. However, since 1987 a major body of evi- 
dence has revealed that proteins require a substantial period of 
time after synthesis (5 min to over an hour [22-24]), during 
which they fold to assume a transport-competent structure. 
Therefore, the kinetics of glycotripeptide secretion do not rule 
out a concentration effect for proteins. In fact, in a recent 
publication [25], it was shown that VSV G protein is concen- 
trated into ER transport vesicles. However, it should be noted 
that this concentration does not necessitate any signal-medi- 
ated uptake into vesicles. Newly synthesized (i. e. newly folded) 
proteins as a class may be directed into budding vesicles as they 
are released from chaperones, a mechanism that at the same 
time would explain the phenomenon of quality control. An- 
other explanation for concentration of cargo membrane pro- 
teins into transport vesicles is that the ER membrane is densely 
populated by resident proteins, thus leaving only little space for 
secretory membrane proteins such as the VW G protein, 
whereas transport vesicles, lacking the bulk of ER-resident 
proteins, can accomodate larger amounts of cargo per unit 
membrane area. These questions have been discussed in a re- 
cent review [26]. 
On the other hand, the rate of flow of glycopeptide and 
truncated lipid markers through the Golgi is about the same as 
that of proteins [27,28], and so the conclusion that cargo is not 
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further concentrated uring intra-Golgi vesicle budding stands, 
also consistent with direct measurement [29]. 
In any case, based on a variety of data ([1,2], and the results 
reported here), we conclude that at least the fraction of sialyl- 
ated glycotripeptides represents a valid marker for vesicular 
bulk flow from the ER via the complete Golgi apparatus to the 
plasma membrane in mammalian cells. 
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